On January 17th, Dr. Hristina Obradović, a research associate in the Group for Hematology and Stem Cells and coordinator of the Amnio Print Care project, delivered an insightful Scientific Seminar at the Institute for Medical Research.
Dr. Obradović presented the preliminary outcomes of her team’s pioneering research, which investigates the usage of placental tissue to develop biopolymers suitable for 3D bioprinting.
“At the outset of this project, our biggest hurdles were centered around optimizing the process of extracting biomaterials from placental tissue. The intricacies of 3D bioprinting and tissue engineering demand meticulous attention to detail, extensive literature reviews, and precise process refinement. However, we’ve discovered effective ways to navigate these challenges, bringing us closer to creating the ideal biomaterial,” explained Dr. Obradović.
This emerging technology holds great promise in significantly enhancing the post-mastectomy recovery process, due to the regenerative and antitumor properties inherent to placental tissue and its ability to minimize immune response. Furthermore, 3D bioprinting facilitates a highly personalized approach to tissue modeling, tailored specifically to the individual needs of patients undergoing surgical reconstruction.
Find all previous Scientific Seminars on the Institute’s YouTube channel.
Follow the Institute for Medical Research on LinkedIn.
Follow the Institute for Medical Research on X.
